| Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers Y Eso, T Shimizu, H Takeda, A Takai, H Marusawa Journal of gastroenterology 55 (1), 15-26, 2020 | 154 | 2020 |
| Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma H Nishikawa, T Inuzuka, H Takeda, J Nakajima, F Matsuda, A Sakamoto, ... BMC gastroenterology 11, 1-12, 2011 | 105 | 2011 |
| Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis H Takeda, A Takai, T Inuzuka, H Marusawa Journal of gastroenterology 52, 26-38, 2017 | 86 | 2017 |
| Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and … H Nishikawa, T Inuzuka, H Takeda, J Nakajima, A Sakamoto, S Henmi, ... Journal of gastroenterology 46, 1418-1426, 2011 | 73 | 2011 |
| Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes H Nishikawa, Y Osaki, E Iguchi, H Takeda, F Matsuda, J Nakajima, ... Journal of gastroenterology 48, 951-965, 2013 | 52 | 2013 |
| Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma H Nishikawa, Y Osaki, T Inuzuka, H Takeda, J Nakajima, F Matsuda, ... World journal of gastroenterology: WJG 18 (12), 1379, 2012 | 51 | 2012 |
| Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report T Inuzuka, H Nishikawa, A Sekikawa, H Takeda, S Henmi, A Sakamoto, ... Oncology 81 (Suppl. 1), 152-157, 2011 | 45 | 2011 |
| Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis SK Kim, H Takeda, A Takai, T Matsumoto, N Kakiuchi, A Yokoyama, ... Journal of gastroenterology 54, 628-640, 2019 | 42 | 2019 |
| The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal … H Nishikawa, Y Osaki, E Iguchi, Y Koshikawa, S Ako, T Inuzuka, H Takeda, ... Journal of Clinical Gastroenterology 47 (4), 359-366, 2013 | 42 | 2013 |
| TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease‐related hepatocellular carcinoma S Ki Kim, Y Ueda, E Hatano, N Kakiuchi, H Takeda, T Goto, T Shimizu, ... International journal of cancer 139 (11), 2512-2518, 2016 | 41 | 2016 |
| Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma T Arizumi, K Ueshima, H Takeda, Y Osaki, M Takita, T Inoue, S Kitai, ... Journal of Gastroenterology 49, 1578-1587, 2014 | 40 | 2014 |
| Pretreatment neutrophil-to-lymphocyte ratio as a predictive marker of response to atezolizumab plus bevacizumab for hepatocellular carcinoma Y Eso, H Takeda, K Taura, A Takai, K Takahashi, H Seno Current Oncology 28 (5), 4157-4166, 2021 | 39 | 2021 |
| Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan H Takeda, H Nishikawa, Y Osaki, K Tsuchiya, K Joko, C Ogawa, ... Liver international 35 (5), 1581-1589, 2015 | 35 | 2015 |
| Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients H Nishikawa, R Kita, T Kimura, Y Ohara, H Takeda, A Sakamoto, S Saito, ... Journal of Cancer 5 (7), 590, 2014 | 35 | 2014 |
| Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients. H Nishikawa, Y Osaki, E Iguchi, H Takeda, Y Ohara, A Sakamoto, ... Journal of Gastrointestinal & Liver Diseases 21 (4), 2012 | 31 | 2012 |
| Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion H Takeda, N Nishijima, A Nasu, H Komekado, R Kita, T Kimura, M Kudo, ... Hepatology Research 49 (5), 594-599, 2019 | 30 | 2019 |
| Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions Y Eso, A Takai, H Takeda, T Matsumoto, M Lee, T Inuzuka, K Takahashi, ... European journal of gastroenterology & hepatology 28 (12), 1462-1467, 2016 | 30 | 2016 |
| Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score … H Nishikawa, Y Osaki, M Endo, H Takeda, K Tsuchiya, K Joko, C Ogawa, ... International journal of oncology 45 (6), 2295-2302, 2014 | 30 | 2014 |
| Sorafenib therapy for BCLC stage B/C hepatocellular carcinoma; clinical outcome and safety in aged patients: a multicenter study in Japan H Nishikawa, H Takeda, K Tsuchiya, K Joko, C Ogawa, H Taniguchi, ... Journal of Cancer 5 (7), 499, 2014 | 29 | 2014 |
| Effect of treatment with branched‐chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma H Takeda, H Nishikawa, E Iguchi, Y Ohara, A Sakamoto, S Saito, ... Hepatology Research 44 (3), 302-312, 2014 | 27 | 2014 |
